These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23190063)

  • 21. Familial hypercholesterolaemia: optimum treatment strategies.
    Ballantyne CM
    Int J Clin Pract Suppl; 2002 Jul; (130):22-6. PubMed ID: 12296605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel pharmacotherapies of familial hyperlipidemia.
    Drakopoulou M; Toutouzas K; Stefanadis C
    Pharmacol Ther; 2013 Sep; 139(3):301-12. PubMed ID: 23639874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia.
    Miltiadous G; Saougos V; Cariolou M; Elisaf MS
    Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing homozygous familial hypercholesterolaemia from cradle to grave.
    Thompson GR
    Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is detection and treatment of familial hypercholesterolemia indicated in children?].
    Bakker HD; Wiegman A; Defesche JC; Kastelein JJ
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2548-51. PubMed ID: 9555154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
    Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
    J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
    van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of lipid-lowering treatment on natural history of heterozygous familial hypercholesterolemia in past three decades.
    Elis A; Zhou R; Stein EA
    Am J Cardiol; 2011 Jul; 108(2):223-6. PubMed ID: 21545982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of high cholesterol levels suggestive of familial hypercholesterolemia in Brazilian adolescents: Data from the study of cardiovascular risk in adolescents.
    Kaestner TL; Bento VF; Pazin DC; Baena CP; Olandoski M; Abreu GA; Kuschnir MCC; Bloch KV; Faria-Neto JR
    J Clin Lipidol; 2018; 12(2):403-408. PubMed ID: 29429893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing early cardiovascular death in patients with familial hypercholesterolemia.
    Repas TB; Tanner JR
    J Am Osteopath Assoc; 2014 Feb; 114(2):99-108. PubMed ID: 24481802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type of LDLR mutation and the pharmacogenetics of familial hypercholesterolemia treatment.
    Santos PC; Pereira AC
    Pharmacogenomics; 2015; 16(15):1743-50. PubMed ID: 26427613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation in a subject with familial hypercholesterolemia carrying the homozygous p.W577R LDL-receptor gene mutation.
    Schmidt HH; Tietge UJ; Buettner J; Barg-Hock H; Offner G; Schweitzer S; Dedoussis GV; Rodeck B; Kallfelz HC; Schlitt HJ; Oldhafer K; Klempnauer J
    Clin Transplant; 2008; 22(2):180-4. PubMed ID: 18339137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
    Saito Y; Shinomiya M; Shirai K; Yoshida S
    Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
    [No Abstract]   [Full Text] [Related]  

  • 35. [Familial hypercholesterolemia].
    Turpin G; Bruckert E
    Ann Med Interne (Paris); 1999 Dec; 150(8):605-14. PubMed ID: 10686642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
    Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
    Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.
    Buonuomo PS; Macchiaiolo M; Leone G; Valente P; Mastrogiorgio G; Gnazzo M; Rana I; Gonfiantini MV; Gagliardi MG; Romano F; Bartuli A
    Eur J Prev Cardiol; 2018 Jul; 25(10):1098-1105. PubMed ID: 29785886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.
    Vergopoulos A; Bajari T; Jouma M; Knoblauch H; Aydin A; Bähring S; Mueller-Myhsok B; Dresel A; Joubran R; Luft FC; Schuster H
    Eur J Hum Genet; 1997; 5(5):315-23. PubMed ID: 9412789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
    Shichiri M; Tanaka A; Hirata Y
    Gene Ther; 2003 May; 10(9):827-31. PubMed ID: 12704424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.